Launching Our SPAC IPO Terms Tracker
by Matt Cianci on 2020-12-30 at 12:10pm

Investors are likely already aware of the SPAC market’s uncanny ability to change on a dime. And this year’s SPAC market was nothing short of dynamic as we had periods where most shares traded below $10 to be followed up by weeks with record setting IPOs shortly thereafter (both in number and size of the IPOs).

We also saw our first SPAC since 2013 go to market with just a share (no warrant or right included in the unit) back on July 8th (Therapeutics Acquisition Corp. – RACA), which was one of 11 warrant-less IPOs in 2020. Yet while some teams took advantage of looser terms, others still had to sweeten their unit to satiate investors’ appetites. Less than four days before Dragoneer II upsized its IPO without a warrant, Better World took a “golden sombrero” where it downsized, increased warrant coverage, and added to trust all in the same filing.

All this is to say what investors intuitively already know to be true: there is a clear bifurcation of terms among SPAC teams coming to market.  The higher profile, brand-name teams can IPO with relative ease, versus everyone else battling a tightening of terms in a crowded market. At a higher level, this has made the market a tough one to judge. It seems to have never been more difficult than it is right now to answer the question “How’s the SPAC market doing?”. At risk of oversimplifying one of the more nuanced corners of Wall Street, we have begun tracking weekly changes in SPAC S-1’s to gauge the market’s risk-appetite.

Specifically, the “tracker” follows every SPAC on file to IPO, from the first S-1 to the prospectus. At the end of every week, we tally each SPAC’s offering amount, warrants & rights in the unit, duration of the trust (in months), and the trust’s funding percentage.

We’ve been tracking week over week changes since October 23rd, where a downsize, more dilutive securities, additions to trust, and shortening duration are all negative changes. The reverse logic would indicate positive changes. Each week the output below shows the positive and negative changes, as well as the “no changes”.

The output allows us to track whether there were more positive changes than negative changes, as well as create a diffusion methodology, similar to the PMI and ISM indices many investors watch. The diffusion oscillates around 50.0 as it assigns a 1.0 value to all positive changes, a 0.5 value to “no changes”, and a 0.0 value to negative changes. Readings above 50.0 would therefore indicate SPAC terms were loosening on the week, while a reading below 50.0 signals tightening.

Further, comparing data points week over week could show comparatively whether or not terms are loosening or tightening further. Last week’s reading of 50.7, for instance, showed terms were still loosening, though at a smaller clip than the high seen two weeks prior.

SPAC IPO TERMS TRACKER

Perhaps this is stating the obvious, but the last three weeks have seen a significant loosening in terms. It was also the smallest number of term changes (five) since the week of the election. The above chart shows our diffusion index (blue line) broke above 50 for the first time the week of December 11th since we began tracking the data the week of October 23rd. During this time, we saw many SPACs coincidentally rise above their cash in trust amount, suggesting greater risk-appetite from investors, and confirmed by the rise in IPO proceeds week-over-week.

At this point it is too early to tell if our diffusion index will be dubbed a leading indicator, but at the very least it can serve as a coincident barometer for SPAC teams, allocators and bankers looking to gauge risk appetite. And for those writing their year-end letters to clients, we hope the graphic helps put pen to paper.

We plan to publish the above chart every week going forward on the SPAC Statistics page.

 

Launching Our SPAC IPO Terms Tracker
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

by Henrique Santa Rosa, CFA on 2025-07-01 at 11:09am

In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...

by Kristi Marvin on 2025-07-01 at 8:42am

An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...

by Nicholas Alan Clayton on 2025-07-01 at 8:25am

At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...

by Nicholas Alan Clayton on 2025-06-30 at 9:04pm

NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved